Mayne Pharma | MYX - Ebit

Keuangan

AUD

AUD 1.14B

AUD 110.07M

Biaya Penjualan

AUD 43.74M

AUD 460.59M

Kewajiban Lancar

AUD 313.94M

AUD 38.82M

AUD -16.2M

AUD 20.9M

450

Eps Laba Per Saham

AUD -0.15

Modal Dan Cadangan

AUD 454.19M

Laba Kotor Pada Penjualan

AUD 86.13M

Beban Bunga Utang

AUD 1.2M

AUD 2.66M

Kapitalisasi Pasar

AUD 230.55M

Batas Pemasukan

AUD -103.68M

Biaya Operasional

AUD 103.54M

Laba Operasional

AUD -3.3M

Modal Saham Biasa

AUD 81.25M

Laba Sebelum Pajak

AUD -14.7M

Pendapatan Penjualan

AUD 212.07M

Beban Penjualan Dan Administrasi

AUD 54.8M

AUD 74.63M

Kreditur Perdagangan

AUD 30.25M

Debitur Perdagangan

AUD 193.22M

	Ebit	Perubahan		Tanggal
Ansell	USD 146.5M		29.2M	2025-12
Avita Medical	AUD -10.39M		1.72M	2025-12
Cochlear	AUD 261.1M		13.9M	2025-12
CSL	USD 2.64B		116M	2025-12
Healius	AUD 23.7M		26M	2024-12
Integral Diagnostics	AUD 24.99M		5.08M	2024-06
Medical Developments International	AUD -36K		12.96M	2025-12
Nanosonics	AUD 9.12M		422K	2025-12
Polynovo	AUD 2.06M		1.18M	2025-12
Ramsay Health Care	AUD 541.1M		20.7M	2025-12
ResMed	USD 499.81M		2.22M	2026-03
Sigma Healthcare	AUD 809K		13.76M	2024-12
Sonic Healthcare	AUD 423.94M		80.3M	2024-12
Telix Pharmaceuticals	AUD 8.04M		3.21M	2025-12